Spatial Cognition Assessment in Virtual Reality
Launched by UNIVERSITÉ PARIS CITÉ · Feb 9, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Spatial Cognition Assessment in Virtual Reality," is exploring how virtual reality (VR) can help assess and diagnose unilateral spatial neglect (USN). USN is a condition that often occurs after a stroke on the right side of the brain, causing individuals to have difficulty noticing or responding to things on the left side. The study aims to use VR technology to create a realistic environment where researchers can better evaluate how patients with USN perceive and interact with their surroundings.
If you're interested in participating, the trial is looking for individuals aged 65 to 74 who have experienced a stroke on the right side of their brain. However, individuals with certain conditions, such as epilepsy, severe cognitive impairment, or significant sensory or motor deficits, would not be eligible. Participants can expect to engage in VR activities that will help researchers understand their spatial awareness better. This trial is currently recruiting, and your involvement could contribute to advancing the understanding and treatment of USN, potentially improving the quality of life for many stroke survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • unilateral right stroke
- Exclusion Criteria:
- • epilepsy / migraine
- • craniotomy
- • major sensory/motor deficit
- • severe cognitive impairment
About Université Paris Cité
Université Paris Cité is a leading academic institution dedicated to advancing research and education in the health sciences. As a prominent sponsor of clinical trials, it leverages its interdisciplinary expertise and collaborative approach to foster innovative medical research. The university is committed to enhancing patient care through rigorous scientific investigation, facilitating the translation of research findings into clinical practice. With a focus on ethical standards and regulatory compliance, Université Paris Cité aims to contribute significantly to the understanding and treatment of various health conditions, ultimately improving health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials